Outro Health

📍 New York, United States🗓 Founded 2022👥 21 employees💰 Last funded Jun 2026
We’re building the first digital health solution dedicated to safely discontinuing psychiatric medications, starting with antidepressants. We exist to empower our members with the knowledge, resources, and clinical support they need to safely and sustainably transition to a life free from medication. Outro’s multidisciplinary founding team includes healthcare providers, world-leading researchers, patient advocates, operational experts, designers and people with lived experience of the challenges and gaps left by the current healthcare system. Searching for solutions, our neurobiology-based approach to deprescribing was born out of the patient community and clinically validated, both personally and professionally, by our Co-Founder, Dr. Mark Horowitz. Outro is now accepting clients, and were always searching for healthcare providers and like-minded builders to come help us pioneer and make accessible a new model of holistic mental healthcare.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2022
Founded
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Outro Health?
Outro Health has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did Outro Health last raise funding?
The most recent investment in Outro Health recorded on gritt.io was in June 2026.
When was Outro Health founded?
Outro Health was founded in 2022.
What industry is Outro Health in?
Outro Health operates in Mental Health Care. Find similar Mental Health Care investors on gritt.io.
Where is Outro Health based?
Outro Health is headquartered in New York, United States.